BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

CAPS Rating: 3 out of 5

A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.

Recs

2
Player Avatar mogruith (99.38) Submitted: 6/18/2010 8:45:39 AM : Outperform Start Price: $2.73 BDSI Score: +105.12

Beaten down, recent insider buying, solid balance sheet.

Featured Broker Partners


Advertisement